NYSEARCA:XBI

SPDR S&P Biotech ETF Stock Forecast, Price & News

$152.56

+1.78 (+1.18 %)

(As of 01/22/2021 12:00 AM ET)

Add

Today's Range

$148.81

Now: $152.56▼

$153.30

50-Day Range

$136.20

MA: $146.06▼

$154.22

52-Week Range

$62.94

Now: $152.56▼

$156.67

Volume5.28 million shs

Average Volume4.80 million shs

Market Capitalization$7.95 billion

P/E RatioN/A

Dividend Yield0.19%

BetaN/A

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.

Currency Exposure of XBI

Sector Exposure of XBI

Industry Exposure of XBI

Basic Details

Issuer SSgA

Fund NameSPDR S&P Biotech ETF

Tax ClassificationRegulated Investment Company

SymbolNYSEARCA:XBI

Inception Date1/31/2006

Fund ManagerMichael Feehily, Karl Schneider, Raymond Donofrio

Webwww.spdrs.com

Phone+1-866-7872257

Fund Focus

Asset ClassEquity

BenchmarkS&P Biotech Index

CategorySector

FocusHealth Care

Development LevelDeveloped Markets

RegionNorth America

Fund Statistics

Assets Under Management$5.93 billion

Average Daily Volume$4.83 million

Discount/Premium0.14%

ETF Expenses

Management Fee0.35%

Other Expenses0.00%

Total Expenses0.35%

Fee Waiver0.00%

Net Expenses0.35%

Administrator, Advisor and Custodian

AdministratorSSgA Funds Management, Inc.

AdvisorSSgA Funds Management, Inc.

CustodianState Street Bank and Trust Company

DistributorState Street Global Advisors Funds Distributors, LLC

Transfer AgentState Street Bank and Trust Company

Trustee

Lead Market MakerVirtu Financial

$152.56

+1.78 (+1.18 %)

(As of 01/22/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive XBI News and Ratings via Email

Sign-up to receive the latest news and ratings for XBI and its competitors with MarketBeat's FREE daily newsletter.

SPDR S&P Biotech ETF (NYSEARCA:XBI) Frequently Asked Questions

How has SPDR S&P Biotech ETF's stock been impacted by COVID-19?

SPDR S&P Biotech ETF's stock was trading at $79.00 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, XBI shares have increased by 93.1% and is now trading at $152.56.
View which stocks have been most impacted by COVID-19.

What stocks does MarketBeat like better than SPDR S&P Biotech ETF?

Wall Street analysts have given SPDR S&P Biotech ETF a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but SPDR S&P Biotech ETF wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Is SPDR S&P Biotech ETF a good dividend stock?

SPDR S&P Biotech ETF pays an annual dividend of $0.28 per share and currently has a dividend yield of 0.19%.
View SPDR S&P Biotech ETF's dividend history.

What other stocks do shareholders of SPDR S&P Biotech ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SPDR S&P Biotech ETF investors own include Intel (INTC), NVIDIA (NVDA), Pfizer (PFE), Gilead Sciences (GILD), iShares Nasdaq Biotechnology ETF (IBB), The Walt Disney (DIS), Micron Technology (MU), Cisco Systems (CSCO), AbbVie (ABBV) and Netflix (NFLX).

Who are SPDR S&P Biotech ETF's key executives?

SPDR S&P Biotech ETF's management team includes the following people:

James E. Ross, President, Trustee (Age 52)
Peter A. Ambrosini, Chief Compliance Officer (Age 69)
Michael P. Riley, Vice President (Age 44)
Gary L. French, Treasurer (Age 64)
John W. Clark, Assistant Treasurer (Age 46)
Matthew W. Flaherty, Assistant Treasurer (Age 42)
Chad C. Hallett, Assistant Treasurer of Street tracks series trust (Age 47)
Mary Moran Zeven, Secretary (Age 52)
Scott M. Zoltowski, Assistant Secretary (Age 44)
Dave Kelly, Independent Trustee

What is SPDR S&P Biotech ETF's stock symbol?

SPDR S&P Biotech ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "XBI."

Who are SPDR S&P Biotech ETF's major shareholders?

SPDR S&P Biotech ETF's stock is owned by a variety of institutional and retail investors. Top institutional investors include Cumberland Advisors Inc. (0.34%), McGuire Investment Group LLC (0.26%), BTR Capital Management Inc. (0.18%), LVM Capital Management Ltd. MI (0.14%), Autus Asset Management LLC (0.11%) and Parkside Investments LLC (0.08%).

Which major investors are selling SPDR S&P Biotech ETF stock?

XBI stock was sold by a variety of institutional investors in the last quarter, including Avantax Advisory Services Inc., Parkside Investments LLC, Shulman DeMeo Asset Management LLC, Brookstone Capital Management, Autus Asset Management LLC, BTR Capital Management Inc., Kestra Private Wealth Services LLC, and N.E.W. Advisory Services LLC.

Which major investors are buying SPDR S&P Biotech ETF stock?

XBI stock was acquired by a variety of institutional investors in the last quarter, including Cumberland Advisors Inc., McGuire Investment Group LLC, Kestra Advisory Services LLC, Aurora Investment Managers LLC., McAdam LLC, Welch & Forbes LLC, Marotta Asset Management, and Conservest Capital Advisors Inc..

How do I buy shares of SPDR S&P Biotech ETF?

Shares of XBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is SPDR S&P Biotech ETF's stock price today?

One share of XBI stock can currently be purchased for approximately $152.56.

How big of a company is SPDR S&P Biotech ETF?

SPDR S&P Biotech ETF has a market capitalization of $7.95 billion.

What is SPDR S&P Biotech ETF's official website?

The official website for SPDR S&P Biotech ETF is www.spdrs.com.

How can I contact SPDR S&P Biotech ETF?

SPDR S&P Biotech ETF's mailing address is One Lincoln Street, Boston, 02111, United States. The exchange traded fund can be reached via phone at +1-866-7872257.

This page was last updated on 1/23/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.